Fatigue in Cancer and HIV/AIDS

ONCOLOGY

Volumn 12, Issue 3, 1998, Pages 335-344

  Groopman, Jerome E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; CANCER; DEPRESSION; FATIGUE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; NUTRITIONAL DEFICIENCY; PAIN; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; QUALITY OF LIFE; REVIEW; SLEEP DISORDER;

FATIGUE; HIV INFECTIONS; HUMANS; NEOPLASMS;

EID: 0031956269     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Darko DF, McCutchan JA, Kripke DF. et al. Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. Am J Psychiatry 149:514-520, 1992.
2. O'Dell MW, Meighen M, Riggs RV: Correlates of fatigue in HIV infection prior to AIDS: A pilot study. Disabil Rehabil 18:249-254, 1996.
3. Portenoy RK, Thaler HT, Kornblith AB. et al: Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3:183-189, 1994.
4. Vogelzang NJ, Breitbart W, Cella D, et al.: Patient, caregiver, and oncologist perceptions, of cancer-related fatigue. Results of a tripart assessment survey. Semin Hematol 34(suppl 2):4-12, 1997.
5. Winningham ML, Nail LM, Burke MB, et al.: Fatigue and the cancer experience: The state of the knowledge. Oncol Nurs Forum 21:23-36, 1994.
6. Berglund G, Bolund C, Fornander T. et al: Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Br J Cancer 27:1075-1081, 1991
7. Dow KH, Ferrell BR, Leigh S, et al. An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res Treat 39:261-273, 1996
8. Yellen SB, Cella DF, Webster K, et al.: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) Measurement System. J Pain Symptom Manage 13:63-74, 1997.
9. Breitbart W, McDonald MV, Rosenfeld B, et al.: Fatigue in ambulatory AIDS patients. J Pain Symptom Manage, 1998 (in press).
10. Cleary PD, Fowler FJ Jr. Weissman J. et al: Health-related quality of life in persons with acquired immune deficiency syndrome. Med Care 31:569-580, 1993.
11. Rhodes VA, Watson PM, Hanson BM: Patients" descriptions of the influence of tiredness and weakness on self-care abilities. Cancer Nurs 11:186-194, 1988.
12. Perceptions of fatigue: A patient and physician survey conducted at the International Conference on AIDS, July 8-11, 1996. Ortho Biotech Inc.
13. Blesch KS, Paice JA, Wickham R, et al. Correlates of fatigue in people with breast or lung cancer. Oncol Nurs Forum 18:81-87, 1991.
14. Bruera E, Brenneis C, Michaud M, et al.: Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer. J Pain Symptom Manage 4:59-63, 1989
15. Cassilcth BR, Lusk EJ, Bodenheimer BJ, et al.: Chemotherapeutic toxicity - the relationship between patients' pretreatment expectations and post-treatment results. Am J Clin Oncol 8:419-425, 1985.
16. Irvine DM, Vincent L, Bubela N, et al.: A critical appraisal of the research literature investigating fatigue in the individual with cancer. Cancer Nurs. 14:188-199, 1991
17. Irvine D, Vincent L, Graydon JE. et al: The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy: A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 17:367-378, 1994
18. Love RR, Leventhal H, Easterling DV, et al.: Side effects and emotional distress during cancer chemotherapy. Cancer 63:604-612, 1989
19. Meyerowitz BE, Sparks FC, Spears IK: Adjuvant chemotherapy for breast carcinoma. Psychosocial implications. Cancer 43:1613-1618, 1979.
20. Haylock PJ, Hart LK. Fatigue in patients receiving localized radiation. Cancer Nurs 2:461-467, 1979
21. King KB, Nail LM, Kreamer K, et al.: Patients' descriptions of the experience of receiving radiation therapy Oncol Nurs Forum 12:55-61, 1985.
22. Nerenz DR, Leventhal H. Love RR: Factors contributing to emotional distress during cancer chemotherapy. Cancer 50:1020-1027, 1982.
23. Knobf MT: Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer J Clin Oncol 4:678-684, 1986.
24. Aistars J. Fatigue in the cancer patient: A conceptual approach to a clinical problem. Oncol Nurs Forum 14:25-30, 1987
25. Maxwell MB: When the cancer patient becomes anemic. Cancer Nurs 7:321-326, 1984.
26. Cushman KE: Symptom management: A comprehensive approach to increasing nutritional status in the cancer patient. Semin Oncol Nurs 2:30-35, 1986.
27. Breitbart W: Identifying patients at risk for, and treatment of major psychiatric complications of cancer. Support Care Cancer 3:45-60, 1995.
28. Breitbart W, Bruera E, Chochinov H, et al.: Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage 10:131-141, 1995.
29. Beszterczey A, Lipowski ZJ: Insomnia in cancer patients (letter). Can Med Assoc J 116:355, 1977.
30. Cella D: The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(suppl 2): 13-19, 1997
31. Glaspy J: The impact of epoetin alfa on quality of life during cancer chemotherapy: A fresh look at an old problem. Semin Hematol 34(suppl 2):20-26, 1997.
32. Henry DH, Abels RI: Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia. Results of double-blind and open-label follow-up studies. Semin Oncol 21(suppl 3):21-28, 1994.
33. Ludwig H, Sundal E, Pecherstorfer M, et al.: Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy. Cancer 76; 2319-2329, 1995.
34. Case DC Jr, Bukowski RM, Carey RW, et al.: Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 85,801-806, 1993
35. Leitgeb C, Pecherstorfer M, Fritz E, et al.: Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer 73:2535-2542, 1994.
36. Jacox A, Carr DB, Payne R, et al.: Management of Cancer Pain: Clinical Practice Guideline No. 9. AHCPR publication 94-0592. Rockville, Maryland, US Public Health Service, Agency for Health Care Policy and Research, March 1994.
37. World Health Organization: Cancer Pain Relief and Palliative Care: Report of a WHO Expert Committee, Technical Report Series 804. Geneva, Switzerland, World Health Organization, 1990.
38. Dimeo FC, Tilmann MHM, Bertz, H, et al.: Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autol- ogous peripheral stem cell transplantation. Cancer 79:1717-1722, 1997
39. MacVicar MG, Winningham ML, Nickel S: Effects of aerobic interval training on cancer patients' functional capacity. Nurs Res 38:348-351, 1989.
40. Winningham ML Walking program for people with cancer: Getting started. Cancer Nurs 14:270-276, 1991.
41. Winningham ML, MacVicar MG, Burke CA: Exercise for cancer patients: Guidelines and precautions. Physician Sports Med 14:124-134, 1986.
42. Kaslow RA, Phair JP, Friedman HB. et al: Infection with the human immunodeficiency virus: Clinical manifestations and their relationship to immune deficiency: A report from the Multicenter AIDS Cohort Study. Ann Intern Med 107:474-480, 1987.
43. Lang W, Anderson RE. Perkins H, et al. Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome: The San Francisco Men's Health Study. JAMA 257:326-330, 1987.
44. Mathur-Wagh U, Spigland I, Sacks HS, et al.: Longitudinal study of persistent generalized lymphadenopathy in homosexual men: Relation to acquired immunodeficiency syndrome. Lancet 2:1033-1042, 1984.
45. Metroka CE, Cunningham-Rundles S, Pollack MS, et al.: Generalized lymphadenopathy in homosexual men. Ann Intern Med 99:585-591, 1983.
46. Wilson IB, Cleary PD: Clinical predictors of functioning in persons with acquired immunodeficiency syndrome. Med Care 34:610-623. 1996.
47. Miller RG Jr, Carson PJ, Moussavi RS, et al.: Fatigue and myalgia in AIDS patients. Neurology 41:1603-1607, 1991.
48. Hambleton J: Hematologic complications of HIV infection. Oncology 10:671-680, 1996.
49. Zon LI, Groopman JE: Hematologic manifestations of the human immune deficiency virus (HIV). Semin Hematol 25:208-218, 1988.
50. Vamvakas E, Kaplan HS. Early transfusion and length of survival in acquired immune deficiency syndrome: Experience with a population receiving medical care at a public hospital. Transfusion 33:111-118, 1993.
51. Wenger JD, Whalen CC, Lederman MM. et al: Prognostic factors in acquired immunodeficiency syndrome. J Gen Intern Med 3:464-470, 1988.
52. Groopman JE: Zidovudine intolerance. Rev Infect Dis 12(suppl 5):S500-S506, 1990
53. Schietinger H: A home care plan for AIDS. Am J Nurs 86:1021-1028, 1986.
54. Murry JF, Mills J: State of the an: Pulmonary complications of HIV infection. Am Rev Respir Dis 141:1356-1372, 1991.
55. More awareness needed in treatment of fatigue. AIDS Alert 11(10):115-117, 1996.
56. Klauke S, Falkenbach A, Schmidt K, et al.: Hypogonadism in male patients with AIDS (abstract FB 525). Int Conf AIDS 6:209, 1990.
57. McCorkindale C, Dybevik K, Coulston AM, et al.: Nutritional status of HIV-infected pa- tiants during the early disease stages. J Am Diet Assoc 90,1236-1241, 1990.
58. Grunfeld C, Kotler DP: Wasting in the acquired immunodeficiency syndrome. Semin Liver Dis 12:175-187, 1992.
59. Kotler DP, Wnag J, Pierson RN Jr. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 42:1255, 1985.
60. Hintz S, Kuck J, Peterkin JJ, et al.: Depression in the context of human immunodeficiency virus infection: Implications for treatment. J Clin Psychiatry 51:497-501, 1990.
61. Cella DF, McCain NL, Peterman AH, et al.: Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life Res 5:450-463, 1996.
62. Hays RD, Shapiro MF: An overview of generic health-related quality of life measures for HIV research. Qual Life Res 1:91-97, 1992.
63. Lubeck DP, Fries IF: Changes in quality of life among persons with HIV infection. Qual Life Res 1:359-366, 1992.
64. Mudido PM, Georges D, Dorazio D, et al.: Human immunodeficiency virus type 1 activa tion after blood transfusion. Transfusion 36:860-865, 1996.
65. Brunson ME, Alexander JW: Mechanisms of transfusion-induced immunosuppression. Transfusion 30651-657, 1990
66. Fischl M, Galpin JE, Levine JD, et al.: Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 322:1488-1493, 1990.
67. Henry DH, Beall GN, Benson CA. et al Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy: Overview of four clinical trials. Ann Intern Med 117:739-748, 1992.
68. Phair JP, Abels RI, McNeill MV, et al. Recombinant human erythropoietin treatment: Investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome: Overall results. Arch Intern Med 153:2669-2675, 1993.
69. Rabkin JG, Rabkin R, Wagner G: Testosterone replacement therapy in HIV patients Gen Hosp Psychiatry 17:37-42, 1995.
70. Wagner GJ, Rabkin JG, Rabkin R: A comparative analysis of standard and alternative antidepressants in the treatment of human immunodeficiency virus patients. Compr Psychiatry 37:402-408, 1996.
71. MacArthur RD, Levine SD, Birk TJ: Cardiopulmonary, immunologic and psychologic responses to exercise training in individuals seropositive for HIV (abstract PuB 7327.1. Int Conf AIDS 8:103, 1992.
72. MacArthur RD, Levine SD, Birk TJ: Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons. Med Sci Sports Exerc 25:684-688, 1993.
73. Vazquez E: Don't just sit there Posit Aware 7(1):23-25, 1996.